<DOC>
	<DOCNO>NCT01819961</DOCNO>
	<brief_summary>The aim study assess effect postoperative parenteral fish oil clinical outcome immune function major laparoscopic abdominal surgery .</brief_summary>
	<brief_title>Parenteral Fish Oil Major Laparoscopic Abdominal Surgery</brief_title>
	<detailed_description>Postoperative patient randomize seal envelope receive either 50:50 ( vol/vol ) mixture oil rich medium-chain fatty acid soybean oil ( termed MCT/LCT ) mixture MCT/LCT fish oil Omegaven 7 day . Full blood count , biochemistry coagulation routinely assess . Fresh blood sample centrifuge plasma , red blood cell lymphocytes stored −80°C pending analysis . The primary endpoint number infective complications.Secondary endpoint clinical outcome , length hospital stay , in-hospital mortality , along plasma immunological marker .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Patients undergo elective major laparoscopic abdominal surgery require least 5 day parenteral nutrition Metabolic disease Chronic kidney liver failure Shock Contraindications lipid administration PN 15 day hospitalisation</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>